translated from Spanish: Britain: 91-year-old woman was the first to receive Pfizer vaccine against Covid-19

British health authorities began on Tuesday to deliver the first doses of a COVID-19 vaccine that passed extensive independent checks and reviews, kicking off a global immunization campaign that is expected to gain momentum as more drugs are approved. The first vaccine was first placed in the morning at one of the hospitals that will handle the initial phase of the British programme. Public health authorities asked the population to be patient, because in the early stages only the most at-risk people would be vaccinated. Medical staff will contact patients to arrange appointments, and most will have to wait until next year, until there are enough vaccines to expand the program.” I think it’s very likely that in the future we will look (tuesday) as a turning point in the battle against the coronavirus,” said Simon Stevens, director general of the English National Health Service. The first person vaccinated was Margaret Keenan, a grandmother, who turns 91 next week. He received the injection at Coventry University Hospital at 6:31 a.m. Keenan said he felt “very privileged to be the first person vaccinated against COVID-19.” It’s the best birthday present I could wish for, because it means I’ll finally be able to think about spending time with my family and friends in the next year, after spending most of this year alone,” she said. The first 800,000 doses will be for people over the age of 80 who are hospitalized or have medical appointments as well as residence workers. Among the older Britons who already had an appointment to get vaccinated was Newcastle’s Hari Shukla.” When I got the phone call, I was very excited to have the opportunity to join and participate in that,” the man said. “So we are very, very happy and happy, and excited too.” Buckingham Palace refused to comment on reports that Queen Elizabeth II, 94, and her husband, Prince Philip, 99, would be vaccinated as a public example of the safety of the drug. Public health authorities around the world watched the British deployment as they prepared for the unprecedented task of vaccinating billions of people to end a pandemic that has killed more than 1.5 million people. Although Britain has a consolidated infrastructure for distributing vaccines, it is designed for groups such as schoolchildren and pregnant women, not the entire population. Britain has soon begun the task after British regulators gave the green light on December 2 for the emergency use of the vaccine produced by US pharmaceutical company Pfizer and Germany’s BioNTech. The US and European Union authorities are also analyzing the drug, as well as rival products developed by the US biotechnology company Moderna and a collaborative project between Oxford University and pharmaceutical company AstraZeneca.Russia began on Saturday to administer its Sputnik V vaccine to thousands of doctors, professors and others in dozens of centers in Moscow. The program is considered different because Russia authorized the use of Sputnik V last summer after testing it in just a few dozen people. Britain urgently needs vaccines. The country has suffered 61,000 COVID-19-associated deaths – the highest figure in Europe – and more than 1.7 million contagions. The 800,000 doses of the first round are just a part of what is needed. The government aims to immunize 24 million people, or about 40% of the population, in the first phase of its vaccination programme, which prioritizes those most at risk if they get the disease. After the over-80s and residency workers, the program will expand as the supply increases, to vaccinate people based on their age, starting with the elderly. Britain has agreed to buy millions of doses from seven different manufacturers. Governments around the world have closed agreements with different suppliers to ensure the delivery of products that achieve authorization.



Original source in Spanish

Related Posts

Add Comment